Key points• Androgen receptor pathway inhibitors combined with androgen deprivation therapy is the new standard of management for advanced prostate cancer.• Common indications include previously treated or new, advanced disease, and palliative symptom management.• There is an increased risk of cardiovascular disease and possible reduced seizure threshold.• Primary care can play an important role in reviewing patients on androgen-deprivation therapy for common side effects.
No takes yet. Share an insight, caveat, or question.
Homewood et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: